Apol Singapore Pte. Ltd. (Apol) is a subsidiary of Apol Technologies Group, established in 2002 and listed on the Singapore Exchange since 2004. Apol is a leading provider of life science research, software, and services. The company develops a comprehensive suite of products designed to address all aspects of life science workflows. It offers a range of solutions and services, ranging from workflow optimization to full software platforms that enable the capture, sharing and analysis of data. In addition, Apol provides a wide range of advisory and consulting services to organizations in the life science industry.
Apol’s services are used in areas such as molecular biology, biochemistry, bioinformatics, pharmacology, genetics, cell and tissue biology, and pathology. Its products and services are deployed in research, development, and production applications. Apol also provides data exchange, collaboration and visualization tools for drug discovery and development, medical diagnostics, and other life science sectors.
In addition to the core products and services, Apol also provides software engineering services for custom software solutions. It helps customers with software design and coding, testing, and deployment. The company has comprehensive experience in integrating large databases and systems from multiple sources. Apol is certified in ISO 9001, demonstrating its commitment to quality and customer service.
Apol Technologies Group has offices throughout Asia and a presence in Europe and North America. The company is committed to providing the most innovative solutions and services for the life science industry. Its team is comprised of highly experienced, creative and customer-focused professionals, working together to provide the highest quality products and services.
